Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy. - Wikidata - wikimedia - TriplyDB

Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.

Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.

http://www.wikidata.org/entity/Q37418500

about

Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.Metabolic Remodeling of Cell-Surface Sialic Acids: Principles, Applications, and Recent Advances.A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.Improving Immunotherapy Through Glycodesign

P2860

Q21129299-2C76C0B4-06D6-4C9A-AD52-EA605B4E7DA9 Q26771367-66C50136-7622-4578-A744-E7F5646CFBCA Q27001592-5F00259B-B182-4493-BB7D-133F5DE34F83 Q35741638-C5F9E9CC-8618-45ED-B8BF-F4C77266DBDB Q38452524-FA6FE65B-FF27-4047-A3E7-55730DE2EBDE Q38634704-DE3C339E-91A7-4557-982E-C33223EC7CC8 Q38767397-D0839A84-2DD4-41A0-A23E-98D0B7FDA41D Q38778469-F13CCCCF-B735-4F1C-A96D-2425967250A6 Q39031683-8E81EE24-F1AD-4346-A984-8AB302230EF7 Q59132146-607538E7-337D-4F7C-97FD-7B9749FA954C

P2860

Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.

http://www.wikidata.org/entity/Q37418500

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 April 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Combining synthetic carbohydra ...... ffective cancer immunotherapy.

@en

Combining synthetic carbohydra ...... ffective cancer immunotherapy.

@nl

type

label

Combining synthetic carbohydra ...... ffective cancer immunotherapy.

@en

Combining synthetic carbohydra ...... ffective cancer immunotherapy.

@nl

prefLabel

Combining synthetic carbohydra ...... ffective cancer immunotherapy.

@en

Combining synthetic carbohydra ...... ffective cancer immunotherapy.

@nl

P1433

Q37418500-F8ABBAE6-CEE0-4507-8090-BD9B802432A4

P1476

Q37418500-9C1D9261-D10F-4624-B5BD-82227A31C531

P2093

Q37418500-056B1B26-40F7-4AEF-9E0A-A28C763E173C

Q37418500-192183F3-50CF-44F5-AD5D-CBB7FF08AAF4

Q37418500-3BFE64B2-1533-42FD-B093-0D18AD202016

Q37418500-3CF10352-C53C-4485-8581-3D0FC01A261B

Q37418500-4F7077E8-4ADB-4030-89D7-5D93491F3291

Q37418500-50E0D08A-FD81-472A-A165-A68397BEC313

Q37418500-6C5D6665-2D7E-4635-BE82-BA526C6FECE0

Q37418500-E0FF366A-A5E4-486E-B72F-82286E445F48

P2860

Q37418500-18BB093A-0C70-485F-A543-16D42A92F0C3

Q37418500-2383861F-8637-4B19-A0DE-C997146CB0E9

Q37418500-263416AC-A4DF-4DDE-AD07-FD27A91A4958

Q37418500-268B18EE-985B-499F-B8F4-C95798E5AEDF

Q37418500-2EDACBBD-F6BE-4D85-85CD-93875E2430A5

Q37418500-333A65B8-2C27-42E6-BA1E-10B385DDEC86

Q37418500-5164D5BC-8A07-4D41-8D41-4ECE4A01F73D

Q37418500-558171C8-E2F1-469F-8517-891472FDAD63

Q37418500-5CBA09E9-8AFF-409C-A25A-74DA1047E355

Q37418500-6A930C6A-9D81-4EC9-9F66-457E5E66014B

P2888

Q37418500-0F50CC55-BE7F-4214-AF3E-649CEEB4A94B

P304

Q37418500-3B9B6A23-3D17-4E97-99AF-37A7E45BFC34

P31

Q37418500-8042D9F2-BECA-47F1-BD46-3EEA12B950CB

P356

Q37418500-73248CD5-BBF2-4D51-A47C-C37351B72531

P433

Q37418500-C13E41B2-6CD0-41CA-AD75-367272FC2D55

P478

Q37418500-8D525700-CA8F-4A5C-98A8-B83026668729

P577

Q37418500-2F7C575C-25EA-458D-8F26-208BB897BEBC

P698

Q37418500-49250603-5F57-4D78-A40D-EBFE8A574558

P921

Q37418500-41CB0B09-2B94-4C71-A1C3-7D030D562786

P932

Q37418500-C3815A71-AA13-48A0-AFBC-BB75FAE309B2

P356

S00262-012-1224-6

P1433

Cancer Immunology, Immunotherapy

P1476

Combining synthetic carbohydra ...... ffective cancer immunotherapy.

@en

P2093

Honggang Hu

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Junping Zhang

http://www.w3.org/2001/XMLSchema#string

Lei Qiu

http://www.w3.org/2001/XMLSchema#string

Qianli Wang

http://www.w3.org/2001/XMLSchema#string

Qiuye Wu

http://www.w3.org/2001/XMLSchema#string

Xi Gong

http://www.w3.org/2001/XMLSchema#string

Zhongwu Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors

From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.

Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine Candidates

Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.

Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse

Vaccination with Theratope (STn-KLH) as treatment for breast cancer.

Glycans in cancer and inflammation--potential for therapeutics and diagnostics.

Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell.

Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines

Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions.

P2888

s00262-012-1224-6

P304

2045-2054

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-012-1224-6

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22539085

http://www.w3.org/2001/XMLSchema#string

P921

P932

3874797

http://www.w3.org/2001/XMLSchema#string